B-
Overall grade
B
Financial quality
The sleeper story here is Home Solutions hitting $360M run rate while everyone obsesses over dental market share. This aging-demographic play is growing 23% with real organic expansion, not just acquisition math. Stanley's tariff confidence sounds good until you realize they're burning through inventory cushions with no plan B for when that $100M of imported products needs repricing. The binding constraint isn't demand, it's their reluctance to admit the US implant market is weaker than 'slightly down' suggests. As Stanley said: 'We believe our current and future actions will be effective at mitigating this year's impact from tariffs' - classic management speak for 'we're hoping this works.' My view changes if Home Solutions growth rate holds above 15% organically or if they give specific market share data showing actual implant gains.
The 30-second version
- Home Solutions quietly becoming the real distribution growth driver while everyone obsesses over dental
- Tariff guidance sounds confident but they're betting on inventory cushions that will run out
- US implant market 'slightly down' is management speak for more trouble than they're admitting
What changed this quarter
| Metric | Prior | This quarter |
|---|---|---|
| Total Sales | $3.2B (+5.8% YoY) | $3.2B (-0.1% YoY) |
| Non-GAAP EPS | $1.19 (+80% YoY) | $1.15 (+5% YoY) |
| Operating Margin (Non-GAAP) | 7.46% (+260 bps YoY) | 7.25% (+14 bps YoY) |
| US Dental Equipment Sales | +10.0% YoY | -8.9% YoY |
| US Medical Sales (Ex-PPE) | +7.3% YoY | +4.7% YoY |
| Home Solutions Growth | +8% YoY | +23% YoY (9% organic) |
| Global Specialty Products | +7.2% YoY | +4.3% constant currency |
| Operating Cash Flow | $204M vs -$32M PY | $37M |
Accountability tracked
7 new promises made4 narrative shifts flagged7 prior promises graded
Inside the full report
The complete write-up covers the full promise ledger with kept/missed calls, disclosure-quality scoring, the metrics-vanished check, verification items, and the questions to ask next quarter.
Subscribe to Call Sheet Daily →